PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pediatrics, Section of Allergy and Clinical Immunology, University of Manitoba, Winnipeg, Manitoba, Canada.\', \'Division of Allergy and Immunology, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.\', \'Pediatric Respirology, Alder Hey Children\'s Hospital, Liverpool, UK.\', \'Division of Child Health, University of Liverpool, Liverpool, UK.\', \'Clinical Pharmacology Unit, Faculty of Medicine, Instituto de Medicina Molecular, University of Lisbon, Lisbon, Portugal.\', \'Department of Pediatrics, Santa Maria Hospital, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.\', \'Paediatric Clinical Pharmacology, University of Liverpool, Liverpool, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/ppul.25117
?:hasPublicationType
?:journal
  • Pediatric pulmonology
is ?:pmid of
?:pmid
?:pmid
  • 33058493
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.018
?:rankingScore_hIndex
  • 95
?:title
  • Pediatric asthma and COVID-19: The known, the unknown, and the controversial.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all